Abstract
This article considers the aims of therapy in the patient with flea allergy dermatitis (FAD), and the range of flea-control products, available for use on the animal and in the environment. Removal of the source of antigenic challenge, the flea, from the patient and the patient's environment should be the ultimate aim of therapy. Whilst this is being achieved, symptomatic antipruritic therapy may be indicated to alleviate clinical signs and reduce discomfort. Insecticides are usually required on the animal and in the surrounding environment. Selection of flea-control products is influenced by the biological and therapeutic characteristics of each insecticide and needs to be customised to individual circumstances.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
